TGFB1 and atrial fibrillation: In particular, rat models of AF have shown that relaxin administration is associated with TGF-β, metalloproteinase-2, metalloproteinase-9, and collagen I/III downregulation, which in turn enhance atrial conduction velocity by reverting atrial structural remodeling [169,170].